Built Inside the Problem. Not From Outside It.
Mere is not a startup that saw an opportunity. It is the productization of two decades of clinical practice, practitioner training, and patient data, built by the people who ran the clinics and watched why supplements fail.
The supplement industry is $60 billion a year.
Most of that money goes to static, generic products that have no feedback mechanism, no way to prove they work, and no system for adapting when they don't. Practitioners have always known this. The question was whether clinical intelligence could be delivered at consumer scale.
0–75%
Abandon within 90 days
0
Feedback loops
The Conviction That Takes Twenty Years to Earn
The Clinical Laboratory
Virginia University of Integrative Medicine is established. What begins as a training institution becomes a living laboratory, exposing, year after year, exactly why the supplement industry fails its patients.
The Network Grows
Over a thousand practitioners graduate and begin treating patients across 20+ states. Each one encounters the same frustration: protocols that work in the clinic cannot scale beyond it. The gap between clinical efficacy and consumer delivery becomes undeniable.
The Manufacturing Foundation
Okchundang fulfills over 3.1 million prescriptions. The cyclodextrin capture process is patented (Korean Patent KR 10-1771125). Four hGMP production lines reach 50,000-unit monthly capacity. The infrastructure that most wellness startups spend years trying to build already exists.
The Productization
Two decades of clinical intelligence converge into Mere. Not a startup that identified a market opportunity, the people who spent twenty years inside the problem finally built the solution. NanoActives, Mere Pulse, NORA AI, and the Mere App become a single closed-loop platform.
What Competitors Would Need to Replicate
1,000+
Practitioner Alumni
Trained at VUIM, treating patients across 20+ states. The trust engine for B2B2C distribution.
3.1M+
Prescriptions Fulfilled
Okchundang's four hGMP lines. 50K units/month capacity scaling to 500K+. 3-week lead times.
370+
Published Works
Dr. Lixing Lao's research portfolio. 18,500+ citations. The clinical credibility standard.
20+
States with Practitioners
Active clinical surfaces for controlled rollout, validation, and real-world evidence generation.
